A preliminary investigation of the management of alcohol dependence with naltrexone by primary care providers

American Journal of Medicine

Volumn 103, Issue 6, 1997, Pages 477-482

  O'Connor, Patrick G ^a   Farren, Conor K ^a   Rounsaville, Bruce J ^a   O'Malley, Stephanie S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA GLUTAMYLTRANSFERASE; NALTREXONE;

ALCOHOLISM; ARTICLE; CLINICAL ARTICLE; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG EFFECT; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; HUMAN; MALE; PATIENT COUNSELING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING;

ALCOHOL DRINKING; ALCOHOLISM; COUNSELING; FEMALE; HUMANS; LIVER; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; PRIMARY HEALTH CARE; TREATMENT OUTCOME;

EID: 0031459561     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00271-4     Document Type: Article

References (29)

1. Lewis DC. The role of generalist in the case of the substance-abusing patient. Med Clin North Am. 81:1997;831-843.
2. Buchsbaum DG, Buchanan RG, Centor RM, et al. Screening for alcohol abuse using CAGE scores and liklihood ratios. Ann Intern Med. 115:1991;774-777.
3. Hays JT, Spickard WA. Alcoholism: early diagnosis and intervention. J Gen Intern Med. 2:1987;420-427.
4. Babor TF, Riston EB, Hodgson RJ. Alcohol-related problems in the primary health care setting: a review of early intervention stratiges. Br J Addict. 81:1986;23-46.
5. Babor TF, Grant M. Programme on Substance Abuse: Project on Identification and Management of Alcohol-Related Problems. Report of Phase II: A Randomized Clinical Trial of Brief Interventions in Primary Health Care. 1992;World Health Association, Geneva.
6. Chick J, Ritson B, Connaughton J, et al. Advice versus extended treatment for alcoholism: a controlled study. Br J Addict. 83:1988;159-170.
7. Edwards G, Orford J, Egert S. Alcoholism: a controlled trial of treatment and advice. J Studies Alcohol. 38:1977;1004-1031.
8. Scott E, Anderson P. Randomized controlled trial of general practitioner intervention in women with excessive alcohol consumption. Drug Alcohol Rev. 10:1991;313-321.
9. Sanchez-Craig M. Brief didactic treatment for alcohol and drug-related problems: an approach based on client choice. Brit J Addict. 85:1990;169-177.
10. Wallace P, Cutler S, Haines A. A randomized controlled trial of general practitioner interventions in patients with excessive alcohol consumption. BMJ. 297:1988;663-668.
11. Babor TF, Grant M, Acuda W, et al. A randomized clinical trial of brief interventions in primary care: summary of a WHO project. Addiction. 1994;89;657-660; discussion 660-678.
12. Fleming MF, Barry KL, Manwell LB, et al. Brief physician advice for problem alcohol drinkers. A randomized controlled trial in community-based primary care practices. JAMA. 277:1997;1039-1045.
13. O'Malley SS, Jaffe AJ, Chang G, et al. Naltrexone and coping skills therapy for alcohol dependence. A controlled study. Arch Gen Psychiatry. 49:1992;881-887.
14. Volpicelli JR, Alterman AI, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 49:1992;876-880.
15. Diagnostic and Statistical Manual of Mental Disorders. 3rd ed. Revised :1987;American Psychiatric Association, Washington, DC.
16. Carroll KM, Rounsaville BJ, Gordon LT, et al. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. Arch Gen Psychiatry. 51:1994;177-187.
17. Fasching P, Derfler K, Maca T, et al. Feasibility and efficacy of intensive insulin therapy in type 1 diabetes mellitus in primary care. Diabetic Medicine. 11:1994;836-842.
18. Selwyn PA, Budner NS, Wasserman WC, Arno PS. Utilization of on-site primary care services by HIV-seropositive and seronegative drug users in a methadone maintenance program. Public Health Reports. 108:1993;492-500.
19. Callahan CM, Hui SL, Nienaber NA, et al. Longitudinal study of depression and health services use among elderly primary care patients. J Am Geriatrics Society. 42:1994;833-888.
20. Saitz R, Mayo-Smith MF, Roberts MS, et al. Individualized treatment for alcohol withdrawal. A randomized double-blind controlled trial. JAMA. 272:1994;519-523.
21. Horwitz RI, Gottlieb LD, Kraus ML. The efficacy of atenolol in the outpatient management of the alcohol withdrawal syndrome. Results of a randomized clinical trial. Arch Intern Med. 149:1989;1089-1093.
22. Yates WR, Reed DA, Booth BM, et al. Prognostic validity of short-term abstinence in alcoholism. Alcohol Clin Exp Res. 18:1994;280-283.
23. O'Malley SS, Croop RS, Wroblewski JM, et al. Naltrexone in the treatment of alcohol dependence: a combined analysis of two trials. Psychiatric Annals. 25:1995;681-688.
24. Beresford TP, Blow FC, Hill E, et al. Comparison of CAGE questionnaire and computer-assisted laboratory profiles in screening for covert alcoholism. Lancet. 336:1990;482-485.
25. Yersin B, Nicolet JF, Dercrey H, et al. Screening for excessive alcohol drinking. Comparative value of carbohydrate-deficient transferrin, gamma-glutamyltransferase, and mean corpuscular volume. Arch Intern Med. 155:1995;1907-1911.
26. O'Malley SS, Jaffe AJ, Chang G, et al. Six-month follow-up of naltrexone and psychotherapy for alcohol dependence. Arch Gen Psychiatry. 53:1996;217-224.
27. Volpicelli JR, Clay KL, Watson NT, O'Brien CP. Naltrexone in the treatment of alcoholism: predicting response to naltrexone. J Clin Psychiatry. 56:1995;39-44.
28. Lewis DC. The role of internal medicine in addiction medicine. J Addict Dis. 15:1996;1-17.
29. Babor TF. Brief intervention strategies for harmful drinkers: new directions for medical education. Can Med Assoc J. 143:1990;1070-1076.